Compare · PHR vs RELX
PHR vs RELX
Side-by-side comparison of Phreesia Inc. (PHR) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PHR and RELX operate in Real Estate (Real Estate), so they compete in similar markets.
- RELX is the larger of the two at $65.44B, about 91.9x PHR ($712.1M).
- PHR has been more active in the news (5 items in the past 4 weeks vs 2 for RELX).
- PHR has more recent analyst coverage (25 ratings vs 12 for RELX).
- Company
- Phreesia Inc.
- RELX PLC PLC
- Price
- -
- -
- Market cap
- $712.1M
- $65.44B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- 2015
- News (4w)
- 5
- 2
- Recent ratings
- 25
- 12
Phreesia Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was founded in 2005 and is headquartered in Raleigh, North Carolina.
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest PHR
- President, Network Solutions Linetsky David covered exercise/tax liability with 182 shares (SEC Form 4) (tax liability)
- SEC Form SCHEDULE 13G filed by Phreesia Inc.
- Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results
- Director Munson Gillian was granted 685 shares, increasing direct ownership by 1% to 66,789 units (SEC Form 4)
- Director Goldstein Lainie was granted 377 shares, increasing direct ownership by 0.53% to 70,862 units (SEC Form 4)
- Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies
- MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider
- President, Network Solutions Linetsky David covered exercise/tax liability with 69 shares (SEC Form 4) (tax withholding)
- Principal Accounting Officer Hui Yvonne covered exercise/tax liability with 937 shares and sold $13,617 worth of shares (1,247 units at $10.92) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 21,724 units (SEC Form 4) (tax withholding)
- Director Egbuonu-Davis Lisa sold $5,735 worth of shares (536 units at $10.70) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 37,780 units (SEC Form 4)
Latest RELX
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- 2026 LexisNexis U.S. Home Insurance Trends Report: Claims Severity Reaches All-Time High While Frequency Declines
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC